Impact of allergic rhinitis on quality of life and main risk factor: a study in Jazan region


  • Radeif Shamakhi Department of Otorhinolaryngology and Head and Neck Surgery, Prince Mohammed Hospital, Jizan, Kingdom of Saudi Arabia
  • Musleh Mubarki Department of Otorhinolaryngology and Head and Neck Surgery, Aseer Central Hospital, Asir, Kingdom of Saudi Arabia



Allergic rhinitis, Quality of life, Saudi Arabia


Background: Allergic rhinitis is a common inflammatory disorder that affects the upper respiratory tract. It affects about one-third of the world’s population. The prevalence of rhinitis varies greatly in various countries and also in various parts of the same country. With this disease, the quality of life which includes sleep disturbances, fatigue, diminished memory, depression is decreased because of the direct impact on the life of the patient.

Methods: The present cross-sectional study was conducted on patients over the age of 18 years old who suffered from symptoms of allergic rhinitis between 1 March 2021 to 30 March 2021 in Jizan region

Patients were answered for questionnaires that sent for them online through social media.

Results: A total of 37 participants enrolled. According to the ARIA guidelines, patients were divided into four groups: a moderate to severe intermittent group that comprised the majority of the patients 38%, a mild intermittent group 19%, a moderate to severe permanent group 27%, and a mild permanent group 15%. Among the total of 37 patients, the quality of life was mildly affected in 35% and severely influenced in 65% patients.

Conclusions: In the patients studied in Saudi Arabia's southern area, allergic rhinitis can have a negative impact on sleep quality, mood, and daily activities.


Bousquet J, Neukirch F, Bousquet PJ. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006; 117(1):158-62.

Sih T, Mion O. Allergic rhinitis in the child and associated comorbidities. Pediatr Allergy Immunol. 2010;21(1):e107-13.

Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758-64.

Cibella F, Ferrante G, Cuttitta G. The burden of rhinitis and rhinoconjunctivitis in adolescents. Allergy Asthma Immunol Res. 2015;7(1):44-50.

Fransson M, Benson M, Erjefält JS. Expression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis. Respir Res. 2007;8(1):1-13.

Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009; 124(3):S43-70.

Kalmarzi RN, Khazaei Z, Shahsavar J, et al. The impact of allergic rhinitis on quality of life: a study in western Iran. Biomed Res Ther. 2017;4(9):1629-37.

Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin. 2004;20(3):305-17.

Blaiss MS. Symposium Cont. Important Aspects in management of allergic rhinitis: compliance, cost, and quality of life. Allergy Asthma Proceed. 2003;24:45-9.

Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Pediatr Drugs. 2004; 6(4):233-51.

Valero A, Ferrer M, Sastre J. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic rhinitis and its impact on asthma severity items. J Allergy Clin Immunol. 2007; 120(2):359-65.






Original Research Articles